Overexpression of these miRNAs by TGF-β signaling led to increased EMT, with similar phenotypes observed after TGF-β treatment in vitro, by blocking E-cadherin (CDH1), and promoting Snail and ZEB1 in HCC. This evidence concerns the gene SNAI1 and hepatocellular carcinoma.